PL1568709T3 - Oczyszczanie fibrynogenu - Google Patents

Oczyszczanie fibrynogenu

Info

Publication number
PL1568709T3
PL1568709T3 PL05003017T PL05003017T PL1568709T3 PL 1568709 T3 PL1568709 T3 PL 1568709T3 PL 05003017 T PL05003017 T PL 05003017T PL 05003017 T PL05003017 T PL 05003017T PL 1568709 T3 PL1568709 T3 PL 1568709T3
Authority
PL
Poland
Prior art keywords
fibrinogen
purification
negative
gel
vulnerary
Prior art date
Application number
PL05003017T
Other languages
English (en)
Inventor
Hubert Metzner
Uwe Liebing
Annette Feussner
Joerg Lemmer
Stefan Schulte
Volker Gawantka
Original Assignee
Csl Behring Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csl Behring Gmbh filed Critical Csl Behring Gmbh
Publication of PL1568709T3 publication Critical patent/PL1568709T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C3/00—Dental tools or instruments
    • A61C3/06—Tooth grinding or polishing discs; Holders therefor
    • A—HUMAN NECESSITIES
    • A46—BRUSHWARE
    • A46B—BRUSHES
    • A46B15/00—Other brushes; Brushes with additional arrangements
    • A46B15/0002—Arrangements for enhancing monitoring or controlling the brushing process
    • A46B15/0016—Arrangements for enhancing monitoring or controlling the brushing process with enhancing means
    • A46B15/0032—Arrangements for enhancing monitoring or controlling the brushing process with enhancing means with protrusion for polishing teeth
    • A—HUMAN NECESSITIES
    • A46—BRUSHWARE
    • A46B—BRUSHES
    • A46B7/00—Bristle carriers arranged in the brush body
    • A46B7/04—Bristle carriers arranged in the brush body interchangeably removable bristle carriers
    • A—HUMAN NECESSITIES
    • A46—BRUSHWARE
    • A46B—BRUSHES
    • A46B9/00—Arrangements of the bristles in the brush body
    • A46B9/02—Position or arrangement of bristles in relation to surface of the brush body, e.g. inclined, in rows, in groups
    • A46B9/04—Arranged like in or for toothbrushes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A46—BRUSHWARE
    • A46B—BRUSHES
    • A46B2200/00—Brushes characterized by their functions, uses or applications
    • A46B2200/10—For human or animal care
    • A46B2200/1066—Toothbrush for cleaning the teeth or dentures

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Dentistry (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PL05003017T 2004-02-24 2005-02-12 Oczyszczanie fibrynogenu PL1568709T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004009400A DE102004009400A1 (de) 2004-02-24 2004-02-24 Fibrinogen Reinigung
EP05003017A EP1568709B1 (de) 2004-02-24 2005-02-12 Reinigung von Fibrinogen

Publications (1)

Publication Number Publication Date
PL1568709T3 true PL1568709T3 (pl) 2011-09-30

Family

ID=34745287

Family Applications (2)

Application Number Title Priority Date Filing Date
PL10183940T PL2267025T3 (pl) 2004-02-24 2005-02-12 Oczyszczanie fibrynogenu
PL05003017T PL1568709T3 (pl) 2004-02-24 2005-02-12 Oczyszczanie fibrynogenu

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL10183940T PL2267025T3 (pl) 2004-02-24 2005-02-12 Oczyszczanie fibrynogenu

Country Status (11)

Country Link
US (1) US7550567B2 (pl)
EP (3) EP1568709B1 (pl)
JP (2) JP4965805B2 (pl)
KR (1) KR101195777B1 (pl)
AT (1) ATE509030T1 (pl)
AU (1) AU2005200635B2 (pl)
CA (1) CA2497796C (pl)
DE (1) DE102004009400A1 (pl)
DK (3) DK2267025T3 (pl)
ES (3) ES2409888T3 (pl)
PL (2) PL2267025T3 (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
EP1950225A1 (de) * 2007-01-25 2008-07-30 Octapharma AG Verfahren zur Steigerung von Proteinausbeuten
JP5484041B2 (ja) * 2007-02-23 2014-05-07 学校法人関西学院 蛋白質結晶化剤および蛋白質結晶化剤を用いた蛋白質結晶化方法
WO2008117746A1 (ja) * 2007-03-22 2008-10-02 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 固体状フィブリノゲン製剤
FR2920429B1 (fr) * 2007-08-30 2012-10-05 Lfb Biotechnologies Procede de purification du facteur viii et du facteur von willebrand
EP2077118A1 (en) * 2008-01-07 2009-07-08 Gwo Rei Biomedical Technology Corp. Clottable concentrate of platelet growth factors and preparation method thereof
EP2293776B8 (de) 2008-06-23 2016-05-11 Bio-Products & Bio-Engineering Aktiengesellschaft Lagerstabiles, funktionell intaktes virus-inaktiviertes fibrinogen
CA2740079A1 (en) * 2008-10-08 2010-04-15 Thrombodyne, Inc. Methods of making concentrated fibrinogen- and platelet-containing compositions
US8314211B2 (en) * 2009-04-07 2012-11-20 George Falus Tissue sealant for use in non compressible hemorrhage
IL213864A0 (en) * 2011-06-30 2011-08-31 Omrix Biopharmaceuticals Ltd Method for removing a lytic enzyme from a heterogeneous mixture
RU2663792C2 (ru) 2012-03-13 2018-08-09 Октафарма Аг Способ очистки фибриногена, продукт фибриногена и средство для очистки или производства продукта фибриногена
TR201902450T4 (tr) * 2012-12-05 2019-03-21 Csl Behring Gmbh Terapötik proteinleri saflaştırma yöntemi.
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
US20140154233A1 (en) * 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
CN104148037A (zh) * 2014-08-08 2014-11-19 华东理工大学 一种精氨酸键合型亲水色谱固定相及制备方法
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
KR101841587B1 (ko) 2016-01-12 2018-05-14 주식회사 녹십자홀딩스 피브리노겐의 정제방법
US11415493B2 (en) 2016-03-17 2022-08-16 Perkinelmer Health Sciences B.V. Detection of cells in a liquid sample
FR3053592B1 (fr) * 2016-07-06 2020-05-29 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Fibrinogene liquide stable
JP2019524704A (ja) * 2016-07-06 2019-09-05 ラボラトワール・フランセ・デュ・フラクシオンマン・エ・デ・ビョテクノロジーＬａｂｏｒａｔｏｉｒｅ Ｆｒａｎｃａｉｓ Ｄｕ Ｆｒａｃｔｉｏｎｎｅｍｅｎｔ Ｅｔ Ｄｅｓ Ｂｉｏｔｅｃｈｎｏｌｏｇｉｅｓ 安定な液体フィブリノーゲン
EP3556728A1 (en) * 2018-04-16 2019-10-23 Croda Denmark A/S Organically modified mineral micro-particles, methods of preparing the same and uses thereof
CA3161383A1 (en) 2019-12-10 2021-06-17 Vera OTT Method for manufacturing a fibrinogen preparation
CN111848783B (zh) * 2020-07-29 2023-07-04 同路生物制药有限公司 一种人纤维蛋白原的制备方法
AU2022426762A1 (en) 2021-12-30 2024-07-04 Baxter Healthcare Sa Fibrinogen and thrombin solutions for a fibrin sealant and fibrin sealant kit

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4170590A (en) 1974-12-14 1979-10-09 Biotest-Serum-Institut Gmbh Ion exchanger treatment of citrate-stabilized plasma
US4188318A (en) 1975-06-16 1980-02-12 Edward Shanbrom Simplified method for preparation of high yield, high purity Factor VIII concentrate
NZ180199A (en) * 1976-03-04 1978-11-13 New Zealand Dev Finance Method of testing for the presence of elevated plasma liprotein concentration
CA1054052A (en) 1976-08-14 1979-05-08 Edward Shanbrom Simplified method for preparation of high yield, high purity factor viii concentrate
DE2903131A1 (de) * 1978-02-06 1979-08-09 Biotest Serum Institut Gmbh Verfahren zur herstellung eines antihaemophilen globulin a enthaltenden konzentrats neben einem prothrombin-komplex und einer loesung von lagerstabilen serumproteinen
DE2902158A1 (de) 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
US4210580A (en) 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
DE3230849A1 (de) 1982-08-19 1984-02-23 Behringwerke Ag, 3550 Marburg Pasteurisiertes human-fibrinogen (hf) und verfahren zu dessen herstellung
US5043428A (en) 1984-08-31 1991-08-27 Behringwerke Aktiengesellschaft Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
DE3432083A1 (de) 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
ATE52425T1 (de) * 1985-02-04 1990-05-15 Hoffmann La Roche Adsorbens fuer die reinigung von proteinen.
DE3734923C1 (de) 1987-10-15 1989-01-26 Biotest Pharma Gmbh Verfahren zur Herstellung einer sterilen Plasmaproteinloesung,die Fibrinogen und den Gerinnungsfaktor XIII enthaelt
FR2632309B1 (fr) 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
US5094960A (en) 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
DE3904354A1 (de) 1989-02-14 1990-08-16 Behringwerke Ag Pasteurisiertes, gereinigtes von willebrand-faktor-konzentrat und verfahren zu seiner herstellung
US5169936A (en) 1989-04-14 1992-12-08 Biogen, Inc. Protein purification on immobilized metal affinity resins effected by elution using a weak ligand
US5138034A (en) 1989-07-12 1992-08-11 The Green Cross Corporation Method of fractionating plasma proteins
DE3926539A1 (de) 1989-08-11 1991-02-14 Braun Melsungen Ag Verwendung von tentakel-kationenaustauschern zur selektiven eliminierung von low-density-lipoproteinen (ldl), fibrinogen und/oder harnstoff aus fluessigkeiten
DE69229272T2 (de) 1991-09-05 2000-02-03 Baxter International Inc., Deerfield Topischer fibrinogenkomplex
FR2686883B1 (fr) 1992-02-04 1994-05-13 Aquitaine Develop Transf Sanguin Procede de fabrication de fibrinogene de tres haute purete, fibrinogene de tres haute purete obtenu ainsi qu'une composition pharmaceutique le contenant.
US5259971A (en) 1992-03-02 1993-11-09 Cryolife, Inc. Method of preparing fibrinogen
US5639940A (en) 1994-03-03 1997-06-17 Pharmaceutical Proteins Ltd. Production of fibrinogen in transgenic animals
CA2162997A1 (en) 1994-03-18 1995-09-28 Daphne C. Tse Topical fibrinogen complex
EP0771324B2 (fr) 1994-07-14 2011-02-09 CAF-DCF Département Central de Fractionnement de la Croix Rouge S.C.R.L. Concentre de fibrinogene issu de plasma sanguin, procede et installation pour sa preparation
US5510102A (en) 1995-01-23 1996-04-23 The Regents Of The University Of California Plasma and polymer containing surgical hemostatic adhesives
US5723579A (en) 1996-02-02 1998-03-03 Bayer Corporation Fibrinogen binding peptides
US6037457A (en) * 1997-01-31 2000-03-14 The University Of North Carolina At Chapel Hill Method for recombinant fibrinogen production
US5876947A (en) 1997-07-25 1999-03-02 The New York Blood Center, Inc. Monospecific antibody reactive with Fibrinogen and fibrinopeptide B
AU749177B2 (en) 1997-10-23 2002-06-20 Fujimori Kogyo Co. Ltd. Method for purifying thrombin substrates and/or inhibitors or method for eliminating the same
US5783663A (en) 1998-01-23 1998-07-21 Bayer Corporation Peptide ligands for affinity purification of fibrinogen
EP1049716A4 (en) 1998-01-23 2002-07-03 Csl Ltd PURIFICATION OF FIBRINOGEN
GB9807464D0 (en) 1998-04-07 1998-06-10 Pharming Bv Purification of human acid µ-glucosidase
ES2267289T3 (es) 1998-09-24 2007-03-01 Pharming Intellectual Property Bv Purificacion de fibrinogeno a partir de fluidos mediante precipitacion y cromatografia de interaccion hidrofoba.
ES2262340T3 (es) * 1998-09-24 2006-11-16 Pharming Intellectual Property Bv Purificacion del fibrinogeno de la leche mediante el uso de cromatografia de intercambio cationico.
CA2385179A1 (en) 1999-10-08 2001-04-19 David J. Hammond Isoagglutinin-depleted blood compositions and methods of making same
CA2395431C (en) * 1999-12-23 2010-08-17 Csl Limited Separation of fibrinogen from plasma proteases
CA2447789C (en) 2001-05-21 2012-11-06 Omrix Biopharmaceuticals S.A. Removal of plasminogen or plasmin from protein solutions
CN1599616A (zh) * 2001-10-03 2005-03-23 克里斯托弗·J·伍尔弗顿 贮存稳定的人纤维蛋白原溶液
GB0216001D0 (en) * 2002-07-10 2002-08-21 Nat Blood Authority Process and composition

Also Published As

Publication number Publication date
EP2267025B1 (de) 2015-05-13
US20050197493A1 (en) 2005-09-08
ES2409888T3 (es) 2013-06-28
EP2264069A3 (de) 2011-05-04
JP2005239719A (ja) 2005-09-08
JP5713880B2 (ja) 2015-05-07
EP1568709B1 (de) 2011-05-11
AU2005200635B2 (en) 2011-11-10
DK2267025T3 (en) 2015-07-20
US7550567B2 (en) 2009-06-23
JP2012051947A (ja) 2012-03-15
ES2544456T3 (es) 2015-08-31
EP2264069B1 (de) 2013-04-17
DK2264069T3 (da) 2013-07-15
PL2267025T3 (pl) 2015-10-30
CA2497796A1 (en) 2005-08-24
KR20060043134A (ko) 2006-05-15
EP2264069A2 (de) 2010-12-22
EP1568709A2 (de) 2005-08-31
JP4965805B2 (ja) 2012-07-04
EP2267025A2 (de) 2010-12-29
DE102004009400A1 (de) 2005-09-08
ES2365241T3 (es) 2011-09-27
DK1568709T3 (da) 2011-08-22
EP2267025A3 (de) 2011-05-04
CA2497796C (en) 2016-03-29
AU2005200635A1 (en) 2005-09-08
EP1568709A3 (de) 2005-11-02
ATE509030T1 (de) 2011-05-15
KR101195777B1 (ko) 2012-11-05

Similar Documents

Publication Publication Date Title
PL2267025T3 (pl) Oczyszczanie fibrynogenu
FR2737730B1 (fr) Procede de purification de virus par chromatographie
WO2010048192A3 (en) Viral inactivation during purification of antibodies
CR8998A (es) PRODUCCION DE TNFR-Ig Y FUSION DE PROTEINA
MY144484A (en) Methods of purifying anti a beta antibodies
CY1107319T1 (el) Μεθοδος για τον καθαρισμο βακτηριακων κυτταρων και κυτταρικων συστατικων
ATE384742T1 (de) Verfahren zur reinigung von preproinsulin
CA2340863A1 (en) Thrombin preparations and process for their production
SE8304125D0 (sv) Vattenoloslig tannin-beredning samt sett for framstellning derav
ECSP055584A (es) Proceso para la preparación de fibrinógeno
GB2337261A8 (en) Purification of nucleic acid from whole cells witha porous membrane filter under pressure
PL1841863T3 (pl) Sposób oczyszczania czynnika VII
DE602004023065D1 (de) Verfahren zur Reiningung von Vancomycin-Hydrochlorid
ATE228391T1 (de) Verbesserte membran
WO2003009926A1 (fr) Membrane a fibres creuses servant a purifier le sang
RU2013127275A (ru) СПОСОБ СНИЖЕНИЯ И/ИЛИ УДАЛЕНИЯ FXI И FXIa ИЗ РАСТВОРОВ, СОДЕРЖАЩИХ УКАЗАННЫЕ ФАКТОРЫ СВЕРТЫВАНИЯ
KR960705921A (ko) 사람 활성화 단백질 C제제 및 이의 제조 방법(Human activated protein C preparation and process for producing the same)
ATE252592T1 (de) Verfahren zur reinigung von 2-keto-l-gulonic säure
ATE454471T1 (de) Neuartige pufferformulierungen zur isolierung, reinigung und rückgewinnung lang- und kurzkettiger nukleinsäuren
RU2006123543A (ru) Способ очистки интерферона бета
MX2023011371A (es) Purificacion de anticuerpos mediante cromatografia de modo mezclado.
EA200600102A1 (ru) Очистка вариантов her-2
EP1078911A3 (de) Verfahren zum Feinreinigen einer wässrigen Lösung, die eine fermentativ hergestellte organische Säure enthält
ATE528393T1 (de) Verfahren zur reinigung von protein und glucosedehydrogenase
ATE468343T1 (de) Verfahren zur reinigung von tacrolimus